The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

WBZ-TV's Dr. Mallika Marshall reports that according to a study from Mass. General Brigham, only 18% of those eligible for a ...

Learn more about supplements for lung health, including vitamins, minerals, and herbs that support breathing, reduce ...

A new study validates NRG1 gene fusions as a targetable driver of advanced NRG1 fusion-positive cancers, adding support for ...

Lung cancer screening with low-dose CT could have saved tens of thousands of lives — if only we'd listened to the data back ...

Only half of study participants continued to get annual lung cancer screenings at least two years after their first.

Pembrolizumab plus concurrent chemoradiotherapy shows ongoing antitumor activity after about 5 years of follow-up in patients ...

Cigarette smoking declines over the past several decades prevented an estimated 3.8 million lung cancer deaths, according to ...

A study finds only 18% of eligible smokers get lung cancer screenings despite the test being quick and simple. Experts urge ...

Population-weighted estimates showed that fewer than 18% of eligible patients actually got a low-dose CT scan for lung cancer ...

Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...